Search

everythinglearnresearchcommunity

for

Search:↓

Young transgender, gender diverse, and nonbinary people on spironolactone have a low risk of high potassium, so frequent monitoring may not be needed.

Ensure respectful and inclusive care for transgender and gender-diverse patients during surgery.

Oral minoxidil can effectively treat hair loss in transgender and gender-diverse individuals.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Transgender and gender-diverse teens need specialized skin and mental health care.

Australia needs better dermatological guidelines for gender-diverse patients.

The US Military supports transgender health care, but many needed skin procedures aren't covered by insurance.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Facial hair is crucial for gender affirmation, but many face financial barriers to achieving desired results.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Gender-affirming hormone therapy in South Korea aligns with international guidelines and has specific side effects.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Transgender and gender diverse youth often have skin issues like acne and scarring, but few get referred to dermatologists.

Athletic trainers should understand and support the medical needs of transgender and gender-diverse patients.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Estrogen alone can lower testosterone in some transfeminine people.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Inclusive and culturally competent healthcare is crucial for transgender and non-binary individuals.

Few dermatology programs mention gender-affirming care, highlighting a need for better training and visibility.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.

Gender-diverse individuals face more depression and anxiety, possibly due to unique stress profiles.

Gender identity can be more diverse than just male or female.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.